INTERNATIONAL PATENT: EISAI R&D MANAGEMENT CO., LTD., ZHANG, YAN JANE FILES APPLICATION FOR "BIOMARKERS FOR ERIBULIN-BASED ANTIBODY-DRUG CONJUGATES AND METHODS OF USE"

GENEVA, April 21 -- EISAI R&D MANAGEMENT CO., LTD. (6-10 Koishikawa 4-chome, Bunkyo-kuTokyo, 112-8088), ZHANG, Yan Jane (c/o Eisai Inc.200 Metro BoulevardNutley, New Jersey 07110) filed a patent application (PCT/US2024/051250) for "BIOMARKERS FOR ERIBULIN-BASED ANTIBODY-DRUG CONJUGATES AND METHODS OF USE" on Oct 14, 2024. With publication no. WO/2025/081160, the details related to the patent application was published on Apr 17, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): FURUUCHI, Keiji (c/o Eisai Inc.200 Metro BoulevardNutley, New Jersey 07110), UENAKA, Toshimitsu (c/o Eisai Inc.200 Met...